End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.13 CNY | -2.36% | -2.80% | -13.87% |
Apr. 08 | Shenzhen Xintai Pharmaceutical's Drug to Treat Chronic Heart Failure Set for Clinical Trials | MT |
Mar. 26 | Salubris Pharma's Profit, Revenue Slip in 2023 | MT |
Business Summary
Number of employees: 3,517
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Preparation
78.7
%
| 2,933 | 84.2 % | 2,650 | 78.7 % | -9.63% |
Raw Materials
12.3
%
| 368 | 10.6 % | 414 | 12.3 % | +12.59% |
Instrument
6.4
%
| 100 | 2.9 % | 216 | 6.4 % | +114.63% |
Others
2.5
%
| 81 | 2.3 % | 86 | 2.5 % | +5.42% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 3,482 | 100.0 % | 3,365 | 100.0 % | -3.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 21-09-30 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Ping Chen
PRN | Corporate Officer/Principal | 53 | 99-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 98-11-02 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Hou Jia Zhu
BRD | Director/Board Member | 59 | 21-04-18 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 21-12-16 |
Lai Ping Liu
BRD | Director/Board Member | 54 | 20-01-09 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yang Bing Li
BRD | Director/Board Member | 44 | 01-06-30 |
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,114,816,535 | 427,127,816 ( 38.31 %) | 23,457,523 ( 2.104 %) | 38.31 % |
Company contact information
Shenzhen Salubris Pharmaceuticals Co., Ltd.
37/F, Main Building Chegongmiao Greenview Plaza
518040, Shenzhen
+
http://www.salubris.cnSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.87% | 4.34B | |
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+9.05% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.64% | 5.09B |
- Stock Market
- Equities
- 002294 Stock
- Company Shenzhen Salubris Pharmaceuticals Co., Ltd.